Q1 2023 Taysha Gene Therapies Inc Earnings Call Transcript
Thank you for standing by. This is the conference operator. Welcome to the Taysha Gene Therapies First Quarter 2023 Earnings Conference Call. (Operator Instructions) And the conference is being recorded. (Operator Instructions) I would now like to turn the conference over to Hayleigh Collins, Director, Head of Corporate Communications. Please go ahead.
Thank you. Good afternoon, and welcome to Taysha's First Quarter 2023 Financial Results and Corporate Update Conference Call. Earlier today, Taysha issued a press release announcing financial results for the first quarter 2023. A copy of this press release is available on the company's website and through our SEC filings.
Joining me on today's call are Sean Nolan, Pasha's CEO; Sukumar Nagendran, President and Head of Research and Development; Kamran Alam, Chief Financial Officer; and Salman Bhai, Assistant Professor of Neurology at UT Southwestern. We will hold a question-and-answer session following our prepared remarks.
Please note that on today's call, we will be making forward
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |